AR and pachyonychia congenita: Aberrations in tumor suppressor genes (e.g., TP53, PTEN, etc.), rearrangements of transcription genes like E26 transformation-specific (ETS) fusion, and changes in the androgen receptor (AR) signaling pathway are all important genetic alterations influencing PC progression [4].